Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: Comparison with transthoracic echocardiography

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 3, 2013, Pages 240-246

  Puntmann, Valentina O ^a,b   Gebker, Rolf ^b   Duckett, Simon ^a   Mirelis, Jesus ^b   Schnackenburg, Bernhard ^c   Graefe, Michael ^b   Razavi, Reza ^a   Fleck, Eckart ^b   Nagel, Eike ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Cardiac magnetic resonance; Cardiomyopathy; Echocardiography; Post processing; Reproducibility

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART LEFT VENTRICLE CHAMBER DIMENSION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; TRANSTHORACIC ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER;

CONTRAST MEDIA; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84874334814     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes145     Document Type: Article

References (23)

1. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50.
2. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
3. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778-85.
4. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-142.
5. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6.
6. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL et al. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee Update the 1997 Guidelines on the Clinical Application of Echocardiography). Circulation 2003;108:1146-62.
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiography 2006;7: 79-108.
8. Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009;54:1457-66.
9. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
10. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-70.
11. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-7.
12. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
13. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21.
14. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance. J. Cardiovasc Magn Reson 2000;2:271-8.
15. Cottin Y, Touzery C, Guy F, Lalande A, Ressencourt O, Roy S et al. MR imaging of the heart in patients after myocardial infarction: effect of increasing intersection gap on measurements of left ventricular volume, ejection fraction, and wall thickness. Radiology 1999;213:513-20.
16. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E et al. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. J Cardiovasc Magn Reson 2002;4:327-39.
17. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocol. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008;10:35.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
19. Heng MK, Janz RF, Jobin J. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. Am Heart J 1985;110:84-90.
20. Puntmann VO, Jahnke C, Schnackenburg B, Gebker R, Fleck E, Paetsch I. Hypertensive and hypertrophic cardiomyopathies have distinctive phenotypes of myocardial remodelling and deformation: a magnetic resonance imaging study. Am J Cardiol 2010;106:1016-22.
21. Hundley WG, Bluemke D, Bogaert JG, Friedrich MG, Higgins CB, Lawson MA et al. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson 2009; 11:5.
22. Marsan NA, Tops LF, Nihoyannopoulos P, Holman ER, Bax JJ. Real-time three dimensional echocardiography: current and future clinical applications. Heart 2009; 95:1881-90.
23. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE et al. Society for Cardiovascular Magnetic Resonance;Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-65.